Abstract:Many tests have shown cyclooxygenase-2 (COX-2) was closely related to the activation of hepatic stellate cells (HSCs), which further promoting the onset and development of hepatic fibrosis. According to these research findings, a series of glycyrrhetinic acid derivatives were designed and synthesized. Meanwhile, their anti-hepaticfibrotic activities were evaluated in vitro and in vivo. Firstly, in the tests of the cell models, all the compounds displayed anti-proliferative effect on the HSC-T6 activated by (transforming growth factor beta) TGF-beta(1) (10 ng/mL). Among them, compounds 2 and 16 exhibited a stronger activity than the others, and their IC50 values were 17.6 mu M and 30.3 mu M, respectively; both of them were low toxicity to normal HSC-T6 cells and WI38 cells, and they inhibited the activated HSC-T6 cells proliferation by promoting apoptosis and resting them at the G(0)/G(1) phase. Secondly, compounds 2 and 16 displayed strong inhibitory effect on activation of HSCs; they not only inhibited the expression of alpha-SMA and Col1 in the activated HSC-T6 cells, but also decreased the levels of COX-2, TGF-beta(1) and (reactive oxygen species) ROS in a concentration-dependent manner; they down-regulated the levels of three biomarkers in the process of test, but this decrease did not change linearly with the action time of compound. Thirdly, for the rats which induced with (carbon tetrachloride) CCl4, the symptoms of liver fibrosis in rats were significantly alleviated after successive administration the tested compound for 14d; the alpha-SMA level in liver tissue decreased in a concentration dependent manner; and the liver cell necrosis and the fat collagen fiber decreased significantly compared with the positive control group; furthermore, inflammatory infiltration was significantly lower than that of the control. This suggests the compounds possibly are candidates for hepatic fibrosis with promising application in clinic.

Synthesis and Anti-Hepaticfibrosis of Glycyrrhetinic Acid Derivatives with Inhibiting COX-2

Synthesis and Anti-Inflammatory Activities of Glycyrrhetinic Acid Derivatives Containing Disulfide Bond

The design, synthesis, and biological evaluation of novel YC-1 derivatives as potent anti-hepatic fibrosis agents

Synthesis of Novel 2-(Pyridin-2-yl) Pyrimidine Derivatives and Study of Their Anti-Fibrosis Activity

Inhibition of the expression of α-smooth muscle actin in human hepatic stellate cell line, LI90, by a selective cyclooxygenase 2 inhibitor, NS-398

Design, synthesis and biological evaluation studies of novel anti-fibrosis agents bearing sulfoxide moiety

Synthesis and Anti-Liver Fibrosis Activity of Imidazole and Thiazole Compounds Containing Amino Acids

Discovery of 1,8-naphthalidine derivatives as potent anti-hepatic fibrosis agents via repressing PI3K/AKT/Smad and JAK2/STAT3 pathways

Design, synthesis and anti-hepatic fibrosis activity of novel diphenyl vitamin D receptor agonists

Synthesis and Evaluation of Asiatic Acid Derivatives As Anti-Fibrotic Agents: Structure/Activity Studies

Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury.

Enhanced Effects of Novel Oridonin Analog Cyd0682 for Hepatic Fibrosis

Design, Synthesis, and Antifibrosis Activity in Liver of Nonsecosteroidal Vitamin D Receptor Agonists with Phenyl-pyrrolyl Pentane Skeleton

Discovery and Development of Benzene Sulfonamide Derivatives As Anti-Hepatic Fibrosis Agents

Rational design, synthesis and activities of phenanthrene derivatives against hepatic fibrosis

Design, Synthesis, and Antifibrosis Evaluation of 4-(Benzo-[c][1,2,5]thiadiazol-5-yl)-3(5)-(6-methyl- Pyridin-2-yl)pyrazole and 3(5)-(6-methylpyridin- 2-Yl)-4-(thieno-[3,2,-c]pyridin-2-yl)pyrazole Derivatives.

Synthesis and Biological Evaluation of 4-Oxoquinoline-3-carboxamides Derivatives As Potent Anti-Fibrosis Agents

Synthesis and Anti-Liver Fibrosis Research of Aspartic Acid Derivatives

Suppressive Effects of Novel Oridonin Derivative CYD0625 on Activated Hepatic Stellate Cells

Phenylethanol Glycosides from Cistanche Tubulosa Suppress Hepatic Stellate Cell Activation and Block the Conduction of Signaling Pathways in TGF-β1/smad As Potential Anti-Hepatic Fibrosis Agents

Phenylethanol Glycosides from Cistanche tubulosa Suppress Hepatic Stellate Cell Activation and Block the Conduction of Signaling Pathways in TGF-β₁/smad as Potential Anti-Hepatic Fibrosis Agents.